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Previously we described a large collection of cloned human
DNAs that encode chemically defined missense mutations
within the ribosomal protein S14 sequence. We determined
that biologically inactive (i.e. null) alleles resulted primarily
from point mutations targeted to two internal segments of
the S14-coding sequence and designated these functionally
critical regions as domains B and D. Further, we inferred
that structural determinants within domains B and D are
required for proper incorporation of the S14 protein into
nascent 40 S ribosomal particles and/or for the normal
function of mature cytoplasmic ribosomes. In this study we
have used immunofluorescence to monitor the intracellular
trafficking of epitopically labeled human S14 protein
isoforms transiently expressed by cultured Chinese
hamster cells. Data obtained distinguish null alleles of
RPS14 which encode proteins that are not incorporated
into pre-ribosomal subunit particles from null alleles whose
products are compatible with normal ribosome assembly
processes but result in functionally inactive cytoplasmic 40
S ribosomal subunits. Mutations assigned to the first allele
class involve amino acid replacements located within S14
domains B and D; whereas mutations assigned to the
second class are distributed throughout the S14 protein-
coding sequence.
Key words: Human RPS14 gene, Ribosomal protein, Mutant,
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Eukaryotic ribosome assembly is a complex process that
depends on the regulated trafficking of multiple proteins into
and out of the nucleolus (Hadjiolov, 1985; Warner, 1989;
Melese and Xue, 1995). Approximately 80 ribosomal proteins
(r-proteins) are synthesized in the cytoplasm and must be trans-
ported to the nucleolus for assembly with precursor ribosomal
RNAs (pre-rRNAs) to form pre-ribosomal particles. Through
a series of maturation steps involving sequential incorporation
of r-proteins and site-specific pre-rRNA cleavages, nascent
ribonucleoprotein particles are transformed into functional 40
S and 60 S ribosomal subunits. Mature ribosomal subunits then
are exported from the nucleolus to the cytoplasm, where they
are recruited to the cell’s protein biosynthetic machinery
(Khanna-Gupta and Ware, 1989; Bataillé et al., 1990; Ware and
Khanna-Gupta, 1990). A wealth of genetic and molecular data
support this scheme for ribosomal subunit maturation in a
variety of eukaryotic organisms (Warner and Soeiro, 1967;
Kumar and Warner, 1972; Warner, 1989; Moritz et al., 1990,
1991; Deshmukh et al., 1993; Ripmaster et al., 1993; Yeh and
Lee, 1995).
In vertebrates the chromosomal locus encoding the 40 S
ribosomal subunit protein S14, RPS14, is unique in its suit-
ability for detailed genetic and molecular genetic analyses.
Mammalian S14 is composed of 151 amino acids (Boersma et
al., 1979a) and is encoded by a gene that contains five exons
which span ~5 kbp of chromosomal DNA (Rhoads et al., 1986;
Rhoads and Roufa, 1991). Chemically-induced mutations nearthe 3¢ -end of RPS14 in Chinese hamster ovary CHO-K1 cells
are responsible for recessive resistance to the translational
inhibitor emetine; and CHO-K1 cells expressing this
phenotype can be isolated efficiently in tissue culture (Gupta
and Siminovitch, 1977; Boersma et al., 1979a,b; Madjar et al.,
1983; Tasheva and Roufa, 1993). Several wild-type and mutant
RPS14 alleles have been obtained as cloned cDNAs (Rhoads
and Roufa, 1985; Chen et al., 1986; Nakamichi et al., 1986)
and chromosomal segments (Rhoads et al., 1986; Rhoads and
Roufa, 1991) from Chinese hamster and human cells as well
as from a variety of other eukaryotic species (Larkin et al.,
1987; Brown et al., 1988; Larkin et al., 1989; Paz et al., 1989;
Perelman and Boothroyd, 1990; Tyler and Harrison, 1990;
Larson and Rossi, 1991; Aerne et al., 1994; Nelson et al., 1994;
Wilson et al., 1994). Further, CHO cell lines carrying trans-
genic S14 DNA sequences have been constructed to charac-
terize the biological activities of mutationally altered RPS14
genes (Diaz et al., 1990, 1991; Diaz and Roufa, 1992; Roufa,
1996).
In a previous report we described a large collection of cloned
RPS14 DNAs that encode defined missense point mutations
arrayed throughout the human S14 gene (Diaz and Roufa,
1992). The locations and properties of these mutations
suggested that the S14 polypeptide is composed of five genetic
domains, designated A-E, whose boundaries correspond
closely with four of the RPS14 gene’s five exons. S14 protein’s
amino terminal A domain (amino acid residues 1-20) was
unnecessary for biological activity, as none of the mutations
affecting this portion of the gene, including large deletion
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cells. In contrast, two other S14 polypeptide segments (domain
B, amino acids 24-49; and domain D, amino acids 107-131)
were crucial for the ribosomal protein’s biological activity.
Most mutations affecting these regions of the gene, including
conservative amino acid replacements, abrogated the S14
protein’s activity in CHO cells. Accordingly, we concluded that
RPS14 domains B and D include determinants which appar-
ently are necessary for the S14 protein’s incorporation into 40
S pre-ribosomal particles and/or for the normal function of
mature 40 S ribosomal subunits.
To verify this interpretation and further characterize our col-
lection of human RPS14 mutations, we immunologically
labeled nineteen biologically inactive, i.e. null, alleles and
monitored the intracellular fates of these genes’ proteins
following transgenic expression in cultured CHO cells. In this
report, RPS14 null alleles are defined as cloned S14 minigenes
which, when transfected into emetine-resistant CHO cells, do
not restore the emetine-sensitive phenotype associated with
biologically active mammalian RPS14 genes (Boersma et al.,
1979b; Madjar et al., 1982; Rhoads and Roufa, 1985, 1987a;
Diaz and Roufa, 1992).
MATERIALS AND METHODS
Materials
Tissue culture medium (Dulbecco’s modification of Eagle’s minimal
medium), fetal bovine serum, Lipofectamine, Nonidet P40, G418,
Escherichia coli TB1 and the bacterial plasmid pUC13 were obtained
from Life Technologies, Inc. The plasmid pET-3d and a murine mon-
oclonal antibody directed against a 12 amino acid bacteriophage T7
protein 10 epitope (T7.Tag) were products of Novagen, Inc. Normal
goat serum was obtained from Colorado Serum Co., and FITC-labeled
goat anti-murine immunoglobulins (Igs) was purchased from Cappel
Organon Teknika. Restriction endonucleases were from Promega
Corp., Life Technologies, Inc. and New England Biolabs, Inc. E. coli
DNA polymerase (Klenow fragment) was a product of United StatesFig. 1. Diagram of human ribosomal
protein S14 DNA sequence carried by
plasmid pCS14Tag-WT. This DNA
fragment encodes the 12 amino acid
T7.Tag epitope inserted into the TaqI
site in RPS14 exon II as well as the
15 amino acid S14 carboxyl peptide
epitope (highlighted by boxes).
Nucleotide and amino acid sequences
of these epitopes are indicated, as are
restriction endonuclease cleavage
sites mentioned in the text. The
cDNA sequence encoding RPS14
exons II-V is represented by a thick
line, and the cloned segment of
downstream genomic DNA (547 bp),
by a thinner line. Biochemical Corp. Tween-20, saponin, phenylmethylsulfonyl
fluoride, Evans Blue, aprotinin and leupeptin were obtained from
Sigma Chemical Co. [a -32P]dCTP (800 Ci/mmol) and [a -32P]rUTP
(3,000 Ci/mmol) were from DuPont-New England Nuclear Corp. 125I-
labeled Protein A (>30 Ci/mg) was purchased from ICN Biomedicals
Inc. Nitrocellulose filter membranes (Immobilon-NC) were from
Millipore Corp. DNA oligonucleotides were synthesized by the
Biotechnology Core Facility at Kansas State University.
Human RPS14 DNA and protein sequences (Rhoads et al., 1986;
Diaz and Roufa, 1992) are deposited in GenBank under accession
numbers M13641 and M13934. Recombinant plasmids carrying
single-base missense mutations within the human S14 protein-coding
sequence (pMS14-2 to pMS14-90) have been described (Diaz and
Roufa, 1992).
Transgenic expression of epitopically labeled human S14
alleles by cultured CHO cells
All recombinant S14 DNAs were constructed in the plasmid vector
pUC13 using E. coli TB1 as the bacterial host. Human S14 proteins
were immunologically labeled by in-frame insertion of a 57 bp DNA
sequence specifying the T7.Tag epitope. The T7 protein 10 DNA
sequence used was excised from plasmid pET-3d (Studier et al., 1990)
as a 35 bp NcoI-BamHI fragment which was ligated to the BamHI site
of pUC13. After addition of a synthetic 10 bp NcoI-TaqI adapter, the
DNA was introduced as a TaqI fragment into domain A of the human
S14 expression plasmid pCS14-140 (Diaz and Roufa, 1992) between
the codewords specifying Pro-3 and Arg-4. To increase expression of
transgenic human S14, 547 bp of human RPS14 downstream chro-
mosomal DNA, obtained from plasmid pCS14-83 (Overman et al.,
1993), was appended to the construct as an SspI-HindIII DNA
fragment. The resulting plasmid was designated pCS14Tag-WT (Fig.
1).
Mutant RPS14 alleles were labeled with the T7.Tag epitope by
replacement of the Bsu36I-SfiI (284 bp) or Bsu36I-SspI (417 bp) DNA
fragments in pCS14Tag-WT with analogous DNA fragments derived
from cloned mutant genes pMS14-2 through pMS14-90 (Diaz and
Roufa, 1992). pMS14-57 is an allele that carries an amino acid
replacement (Ser-114rPhe) as well as a single-base deletion ( D C382)
(Diaz and Roufa, 1992). pMS14-57A, which harbors only the amino
acid replacement, was constructed by exchanging the 307 bp Bsu36I-
AvaI DNA fragment in pCS14Tag-WT with the comparable fragment
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Fig. 2. Subcellular distribution of human r-protein S14 in stably-
transformed CHO cells. (A) Immunoblot of subcellular protein
fractions. Cytoplasmic proteins (100 m g, lanes 1 and 4), nuclear
proteins (100 m g, lanes 2 and 5) and purified ribosomal proteins (10
m g, lanes 3 and 6) were resolved by electrophoresis through a 12.5%
(w/v) polyacrylamide gel and electroblotted to a nitrocellulose
membrane. Lanes 1-3 were analyzed with polyclonal rabbit anti-S14
carboxyl peptide serum diluted 1/1,000; and lanes 4-6 were analyzed
with monoclonal anti-T7.Tag diluted 1/5,000. Bound antibody was
detected with 125I-labeled Protein A. Molecular sizes of protein
standards analyzed on the same polyacrylamide gel are indicated at
the right of the figure. (B) Indirect immunofluorescence staining
pattern obtained using murine anti-T7.Tag monoclonal antibody and
FITC-labeled goat anti-mouse Igs. Bar, 15 m . of pMS14-57. All recombinant DNA structures were verified by
detailed restriction maps and DNA sequence analyses as described
(Rhoads and Roufa, 1985; Rhoads et al., 1986; Brown et al., 1988;
Diaz et al., 1991; Rhoads and Roufa, 1991; Diaz and Roufa, 1992;
Tasheva and Roufa, 1993).
For transient expression of mutant RPS14 alleles, 100 mm tissue
culture dishes were inoculated with 106 emetine-resistant Emr-2-2
CHO cells (Madjar et al., 1982, 1983; Rhoads and Roufa, 1985) and
cultured for 12-16 hours. Recombinant plasmid DNAs (10 m g)
encoding human S14 alleles were introduced into the cells using the
Lipofectamine-mediated transfection protocol described by that
reagent’s manufacturer (Life Technologies, Inc.). To obtain trans-
formed cell clones that stably express human S14 DNAs, Emr-2-2
cells were co-transfected with pSV2neo (Southern and Berg, 1982)
and RPS14 DNAs using the polybrene-dimethylsulfoxide protocol
described previously (Rhoads and Roufa, 1987a). Efficient transcrip-
tion of recombinant S14 alleles in CHO cells, including biologically
inactive null alleles, was confirmed by RNase A + T1 protection
assays using 32P-labeled human S14 antisense RNA probes (Brown
et al., 1988; Diaz and Roufa, 1992; Overman et al., 1993). The bio-
logical activities of mutated S14 alleles also were assessed pheno-
typically in stably transformed CHO cells using the clonogenic assay
described previously (Diaz and Roufa, 1992).
Preparation of protein samples for immunological analysis
Transiently or stably transformed Chinese hamster cells were scraped
from culture monolayers and washed by centrifugation (500 g, 5
minutes) with phosphate buffered saline (PBS) containing CaCl2 (1
mM), MgCl2 (0.5 mM) and 0.1% (w/v) glucose. Cells were resus-
pended in a buffer composed of 30 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 1 mM MgCl2, 0.5 mM CaCl2, phenylmethylsulfonyl fluoride
(10 m g/ml), leupeptin (2 m g/ml) and aprotinin (2 m g/ml) and lysed by
addition of 0.5% (v/v) NP40 (0°C for 10 minutes). Lysates were
resolved into cytoplasmic, nuclear and ribosomal subfractions by dif-
ferential centrifugation (Boersma et al., 1979a; Madjar et al., 1983)
and ribosomal proteins were extracted from each subcellular fraction
and alkylated for electrophoretic analysis (Boersma et al., 1979a;
Madjar et al., 1982, 1983). 
Immunological detection of human S14 proteins
expressed by CHO cells
Two antisera were used to assess the expression of human S14 alleles
in transformed CHO cells. One was a polyclonal rabbit serum directed
against the carboxyl terminus of mammalian r-protein S14. It was
obtained by immunizing rabbits with a synthetic, 15 amino acid
peptide (S14 Pro-136 through Arg-150, Fig. 1) conjugated to keyhole
limpet hemocyanin (Krishnamachary et al., 1994). Because the amino
acid sequences of human and Chinese hamster S14 are identical
(Rhoads and Roufa, 1985; Rhoads et al., 1986), this antiserum detects
both species’ S14 protein equally well. The other antibody was a mon-
oclonal IgG directed against the T7.Tag epitope (Novagen, Inc.). This
antibody does not react with normal CHO and human proteins, but
efficiently detects recombinant human S14 proteins carrying the
T7.Tag epitope.
Transgenic human S14 proteins expressed by CHO cells were
assayed quantitatively on immunoblots and qualitatively in single
cells by indirect immunofluorescence. For immunoblots, CHO cell
protein samples were resolved by SDS-polyacrylamide gel elec-
trophoresis and electrophoretic transfer to nitrocellulose membranes.
The resulting membranes were incubated at room temperature in a
blocking solution of 1% (w/v) hemoglobin in PBS (2 hours) followed
by incubations with antibody directed against T7.Tag or S14 carboxyl
peptide (8-12 hours) and then with 125I-labeled Protein A (2.5· 105
cpm/ml). After each incubation, membranes were washed extensively
in PBS plus 0.1% (v/v) Tween-20. Nitrocellulose membranes were air
dried before exposure to X-ray film. For indirect immunofluorescence
microscopy, transfected CHO cells were fixed in 80% (v/v) methanolfor 5 minutes. After washing with PBS, cells were treated at room
temperature with 0.5% (w/v) saponin (5 minutes); normal goat serum
plus Evans Blue counterstain (1 hour); an appropriate dilution of
T7.Tag monoclonal antibody (3 hours); and FITC-conjugated goat
anti-mouse Igs (1 hour). All antibody incubations were followed by
extensive washes in PBS containing 0.1% (w/v) saponin. After the
final wash, cells were mounted in glycerol/PBS (1:1) and observed
under ultraviolet light using a Nikon Optiphot epifluorescence pho-
tomicroscope. 
RESULTS
The T7.Tag epitope does not interfere with
incorporation of human S14 into functional 40 S
ribosomal subunits
Inasmuch as human and Chinese hamster S14 proteins are
identical 151 amino acid polypeptides, we used an epitope
tagging strategy to distinguish between transgenic human and
endogenous hamster S14 proteins in cells and extracts prepared
from transfected Emr-2-2 cultures. The T7.Tag epitope was
chosen as the immunological label because it is small (12
amino acid residues) and a commercially available monoclonal
antibody directed against it does not crossreact with
mammalian cell proteins. A DNA fragment encoding T7.Tag
plus seven additional amino acid residues was inserted in frame
into a cloned copy of human RPS14 near the 5¢ -end of exon II,
within the nonessential A domain of the S14-coding sequence
(Diaz and Roufa, 1992). The recombinant r-protein encoded by
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Fig. 3. Subcellular distribution of wild-type and mutant S14
polypeptides transiently expressed by CHO cells. Twenty-four
(B,D,E) or forty-eight (A,C,F) hours after transfection with the
epitopically labeled RPS14 alleles indicated, Emr-2-2 cells were
prepared for indirect immunofluorescence microscopy using murine
anti-T7.Tag monoclonal antibody and FITC-labeled anti-mouse Igs.
T7.tagged S14 polypeptides appear as yellow/green fluorescence.
Cell regions devoid of the epitope as well as non-expressing cells are
visualized with Evans Blue counterstain. The immunofluorescence
patterns shown are as follows: (A) type I immunofluorescence,
pCS14Tag-WT DNA. (B) Type II immunofluorescence, pCS14Tag-
M13 DNA. The M13 null allele carries two point mutations: Phe-
37rLeu and Asp-39 r Gly (Diaz and Roufa, 1992). (C) Type III
immunofluorescence, pCS14Tag-M80 DNA (Met-124rLys; Diaz
and Roufa, 1992). (D) Type IV immunofluorescence, pCS14Tag-M9
DNA (Cys-31rTrp; Diaz and Roufa, 1992). (E) Types I and II
immunofluorescence, pCS14Tag-M58 DNA. M58 specifies two
amino acid replacements: Arg-117rLys and Asp-138rAsn (Diaz
and Roufa, 1992). (F) Immunofluorescence pattern types II and IV,
pCS14Tag-M80 DNA. Bar, 20 m .this construct (pCS14Tag-WT, Fig. 1) is 19 amino acid residues
(~2 kDa) larger than wild-type S14 and, as shown below, can
be detected in cells as well as cell-free extracts using standard
immunological and electrophoretic methods.
To determine whether the T7.Tag insert adversely affected
r-protein S14 function in cultured CHO cells, pCS14Tag-WT
was stably introduced into emetine-resistant Emr-2-2 cells
together with an excess of the selectable plasmid pSV2-neo
(Southern and Berg, 1982). Most of the G418-resistant
colonies isolated from transfected cultures (>85%) were
sensitive to emetine, indicating that the epitopically-labeled
S14 protein functioned well enough to phenotypically mask the
Emr-2-2 drug resistance phenotype. In addition, cloned cell
lines carrying stably integrated pCS14Tag-WT transgenes
expressed both normal S14 (Mr .16,000) and the T7.Tag
fusion S14 protein (Mr .18,000). As illustrated in Fig. 2A,
antiserum directed against the S14 carboxyl epitope revealed
the two S14 proteins on immunoblots of cytoplasmic (lane 1)
and nuclear (lane 2) protein extracts. That both S14 antigens
also were detected among proteins extracted from purified
cytoplasmic ribosomal subunits (lane 3) indicated that T7.Tag
does not interfere with the protein’s incorporation into pre-
ribosomal particles nor does it preclude export of mature 40 S
ribosomal subunits to the cell’s cytoplasm. Indeed, the relative
intensities of the two S14 protein bands observed in cytoplas-
mic extracts (lane 1) and purified ribosomal subunits (lane 3)
suggested that the transgenic fusion protein was expressed and
processed approximately as efficiently as the cells’ endogenous
S14. When the same three protein samples were analyzed with
anti-T7.Tag antibody, only the epitopically-tagged protein (Mr
.18,000) was detected (Fig. 2A, lanes 4-6). Because neither
normal nor epitopically tagged S14 proteins were detected in
post-ribosomal cytosolic supernatant fractions (data not
shown), we concluded that most, if not all, of the cytoplasmic
S14 antigens visualized on immunoblots were contained within
ribosomal subunit particles. In the experiment illustrated, the
protein samples analyzed were optimized to yield comparable
autoradiographic signals. When calculated on a ‘per cell’ basis,
these data indicated that the great majority of cells’ S14 antigen
(>90%) was located within cytoplasmic subcellular fractions.
Only minor fractions of the antigen (generally <10%), pre-
sumably reflecting newly synthesized S14 protein, were
detected among the proteins extracted from CHO cell nuclei.
Indirect immunofluorescence more precisely located the
wild-type fusion S14 protein within Emr-2-2 cells’ nucleoli and
cytoplasm (Fig. 2B). The immunofluorescence staining pattern
obtained with anti-T7.Tag (Fig. 2B) was very similar to that
observed when polyclonal anti-S14 carboxyl peptide antiserum
was used to analyze transfected as well as non-transfected
control cells (data not shown). Taken together, the immuno-
logic and clonogenic data described above demonstrate that:
(1) epitopically labeled pCS14Tag-WT transgene is accurately
expressed by CHO cells; and (2) CHO cells efficiently process
the wild-type S14 fusion protein and incorporate the protein
into functional ribosomal subunits.
Intracellular trafficking of mutated S14 proteins
Nineteen null alleles of human RPS14, each carrying a single
defined amino acid replacement (Diaz and Roufa, 1992), were
labeled with T7.Tag to assess their intracellular processing.
Cells were fixed 24 or 48 hours after transfection for analysisby indirect immunofluorescence. Four distinct immunofluor-
escence patterns were observed (Fig. 3). Cells transiently
expressing the wild-type RPS14 transgene (pCS14Tag-WT)
and several of its mutant alleles (see Table 1, Groups A and B)
displayed intense cytoplasmic and nucleolar fluorescence (Fig.
3A). This immunostaining pattern was identical to the
immunofluorescence observed in CHO cells stably expressing
pCS14Tag-WT (Fig. 2B) and was designated the type I staining
pattern. In contrast, the other S14 null alleles (see Table 1,
Group C) were associated with intense nucleolar and/or nucleo-
plasmic fluorescence only. Cells displaying the type II
immunofluorescence pattern cells showed nucleolar staining
exclusively (Fig. 3B). Cells classified as exhibiting type III
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accompanied by substantial, but variable, staining in the sur-
rounding nucleoplasm (Fig. 3C). Nucleoplasmic fluorescence
was so intense in some type III cells that it obscured stained
nucleoli (Fig. 3D) and therefore was designated as a separate
immunofluorescence phenotype (the type IV pattern).
Although CHO cells transiently expressing wild-type S14
fusion protein showed type I immunofluorescence predomi-
nantly, cells transfected with most of the mutant S14 fusion
genes displayed multiple alternative immunofluorescence
patterns within single microscopic fields. For example,
transient expression of the biologically-active mutant allele
pCS14Tag-M58 produced cells with types I and II immuno-
fluorescence (Fig. 3E); whereas expression of the null allele
pCS14Tag-M80 resulted in cells that displayed types II, III and
IV patterns (Fig. 3C and F). Based on these observations, it
was clear that the four immunofluorescence patterns distin-
guished do not all represent steady-state phenotypes. Rather,
some of the patterns appeared to reflect transition phenotypes
within two distinct temporal sequences.
To investigate temporal relationships among immunoflu-Fig. 4. (A) Immunofluorescence patterns observed during transient
expression of T7.Tagged wild-type and mutant RPS14 alleles. CHO
Emr-2-2 cells were fixed one to four days post-transfection with
wild-type pCS14Tag-WT or mutant pCS14Tag-M3 and pCS14Tag-
M6 transgenes and processed for indirect immunofluorescence
microscopy with monoclonal anti-T7.Tag antibody. At least 100
fluorescent cells were scored for each time point; and cells were
classified as exhibiting types I-IV immunostaining patterns according
to criteria described in the text. (B) Diagram of the temporal
transitions among the immunofluorescence staining patterns inferred
from data illustrated in A.orescence patterns I-IV, the fractions of cells displaying each
pattern were evaluated at sequential times following transfec-
tion with several epitopically-labeled RPS14 alleles (Fig. 4).
As illustrated in Fig. 4A, staining patterns types I and IV were
the two end-state phenotypes observed. Staining patterns II and
III appeared only transiently as cells progressed toward the
types I or IV end-states. As illustrated in Fig. 4B, wild-type
S14 protein transits the cells’ nucleoli (type II immunoflu-
orescence) and accumulates in the cytoplasm as a component
of functional ribosomal particles (type I immunofluorescence).
Few cells that express the wild-type protein displayed nucleo-
plasmic fluorescence (types III and IV fluorescence), suggest-
ing that normal nucleoplasmic pools of free S14 protein and
newly assembled ribosomal subunits are too small to be
detected by indirect immunofluorescence. Cells expressing
some mutated, biologically inactive S14 proteins (e.g. the M6
null S14 protein) also produced a type I steady state staining
pattern, but achieved this fluorescence pattern more slowly than
cells transfected with the wild-type fusion gene (Fig. 4A).
Accordingly, the M6 fusion protein appeared to be transported
into the cells’ nucleoli with normal kinetics, but thereafter was
incorporated into 40 S ribosomal particles and exported to the
cytoplasm more slowly than wild-type S14. Thus, the M6 point
mutation (Thr-45 r Ile; Diaz and Roufa, 1992) appears to
retard, but not preclude, assembly of S14 into pre-ribosomal
particles destined for export to the cytoplasm.
In contrast, cells expressing other null mutant S14 proteins
displayed the type IV immunofluorescence end-state pattern.
As illustrated in Fig. 4A, transgenic M3 fusion protein (Cys-
31 r Ser; Diaz and Roufa, 1992) was transported into CHO
cell nucleoli with normal or near-normal kinetics to produce a
transient type II staining pattern (open circles). However, CHO
cells did not re-export the M3 protein to the cytoplasm. Rather,
the M3 protein accumulated in the cells’ nucleoplasm (staining
patterns types III and IV, shaded and unshaded triangles).
Unusually intense nucleoplasmic fluorescence in these cells
probably indicates free M3 S14 protein trapped in the nucleo-
plasm during its import to the nucleolus. Alternatively, it might
reflect excess unassembled ribosomal protein that has ‘leaked’
from nucleoli with saturated internal pools of S14 protein. In
either case, intracellular trafficking patterns which result in
types III and IV immunofluorescence patterns (indicated dia-
grammatically as the ‘Mutant Pathway’ in Fig. 4B) have been
interpreted to indicate mutations which preclude the S14
protein’s incorporation into nucleolar pre-ribosomal subunit
particles.
Kinetic studies, such as those illustrated in Fig. 4A, were
carried out on nineteen of the mutant S14 DNA clones previ-
ously classified as null alleles (Diaz and Roufa, 1992). Each of
the mutant DNAs was assigned to one of three phenotypic
classes based on the immunofluorescence staining patterns
produced (Table 1). Eleven of the null alleles encode proteins
that resulted in the type I immunofluorescence end-state pattern
illustrated in Fig. 3A. Accordingly, these mutated S14 proteins
appeared to be incorporated into functionally inactive 40 S
ribosomal particles which ultimately produced intense cyto-
plasmic fluorescence. Five of these mutants achieved the type
I end-state with kinetics comparable to the wild-type S14
fusion protein (these are classified as Group A mutations in
Table 1); and six mutants approached the type I end-state
pattern slower than cells expressing pCS14Tag-WT (Group B
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Table 1. Intracellular trafficking of mutant human S14
proteins transiently expressed in cultured Chinese
hamster ovary (CHO) cells*
Clone Amino acid substitution(s) 
A. Mutant S14 proteins that are incorporated into 40 S subunits and transported 
to the cytoplasm normally:
M4 Ser-70rLeu
M5 Lys-50rGlu
M53 Arg-98rLeu
M54 Ala-74rVal
M55 Arg-117rLys
B. Mutant S14 proteins whose incorporation into 40 S subunits and transport 
to the cytoplasm is slower than normal:
M6 Thr-45rIle
M23 Gly-49rAsp
M57A Ser-114 rPhe
M60 Gly-123rSer
M63 Asp-131rAsn
M90 Thr-133rIle
C. Mutant S14 proteins that are neither incorporated into 40 S subunits nor 
transported to the cytoplasm:
M3 Cys-31rSer
M7 Cys-31rTyr
M9 Cys-31rTrp
M17 His-43rTyr
M44 Gly-111rArg
M67 Gly-127rArg
M80 Met-124rLys
M88 Ile-126rAsn
*CHO cells (clone Emr-2-2) expressing the cloned T7.Tagged mutant
RPS14 alleles listed were analyzed by indirect immunofluorescence at several
times following transfection. Transgenes whose products produced type I
immunofluorescence with kinetics similar to the wild-type S14 polypeptide
are listed in group A. Alleles whose peptide products displayed type I
immunofluorescence significantly slower than wild type (such as the mutant
M6 polypeptide shown in Fig. 4A) are listed in group B. Transgenes whose
protein products accumulated within the cells’ nucleoli and nucleoplasm
(types III and IV immunofluorescence) are listed in group C.
Fig. 5. Effects of null mutations on incorporation of r-protein S14
into 40 S ribosomal subunits. The horizontal axis represents the 151
amino acid human S14 sequence. Residue numbers are indicated on
the scale below. Mutations compatible with the S14 protein’s
incorporation into pre-ribosomal subunits are displayed above the
axis; and mutations which preclude the protein’s incorporation into
ribosomal particles are positioned below the axis. Individual amino
acid replacements are identified by the clone numbers listed in Table
1. Conservative amino acid substitutions, as judged by the PAM-250
matrix (Dayhoff, 1978), are represented as circles; and radical amino
acid replacements are represented by squares. The S14 polypeptide’s
genetically-defined functional domains A-E (Diaz and Roufa, 1992)
are indicated at the bottom of the figure. mutations, Table 1). The latter group of mutated fusion proteins
apparently are incorporated into 40 S pre-ribosomal particles
more slowly than wild-type S14 fusion protein. The remaining
eight mutated fusion proteins accumulated within the CHO
cells’ nucleoli and nucleoplasm (as evidenced by types III and
IV immunofluorescence end-state patterns) and therefore were
classified as proteins which are not incorporated into pre-
ribosomal subunits (Group C mutations, Table 1). 
A diagram summarizing the locations and properties of the
S14 null mutations analyzed by indirect immunofluorescence
is illustrated in Fig. 5. In the figure, mutations which yielded
the type I end-state immunofluorescence pattern are positioned
above the horizontal line, whereas mutations that produced
types III and IV end-state patterns are located below the line.
The type I S14 alleles include mutant genes whose products
were incorporated into 40 S ribosomal particles as efficiently
as wild-type S14 protein (Group A alleles) as well as genes
whose products were assembled into ribosomal particles more
slowly (Group B alleles). Consistent with this interpretation,
the type I mutations are distributed across most of the S14
protein-coding sequence and involve an approximately equal
mixture of conservative (circles) and non-conservative
(squares) amino acid replacements. In contrast, the eight trans-genes associated with types III and IV staining patterns (Group
C alleles) carry mutations clustered within RPS14 domains B
and D. These domains previously were identified as critical for
ribosome assembly and function by genetic criteria alone (Diaz
and Roufa, 1992). As might be expected for mutations that
preclude r-protein incorporation into ribosomal particles, most
of the Group C mutations involve non-conservative amino acid
substitutions. Interestingly, the six Group B mutations which
delay S14 protein’s incorporation into nascent 40 S pre-
ribosomal particles (M6, M23, M57A, M60, M63 and M90)
also map to domains B and D. Accordingly, our data indicate
that structural determinants within RPS14 domains B and D
are required for the nucleolar functions that mediate S14 incor-
poration into pre-ribosomal particles.
DISCUSSION
For lack of robust cell-free methods by which to assess intra-
cellular trafficking of mammalian r-proteins and their assembly
into pre-ribosomal subunits, we employed an epitope labeling
strategy and transient expression assay to characterize our col-
lection of human RPS14 null alleles. This assay was based on
the observation that in higher eukaryotic cells newly-synthe-
sized r-proteins are rapidly transported to the nucleolus, where
they are incorporated into pre-ribosomal subunit particles.
When fully assembled and modified, mature ribosomal
subunits are exported to the cytoplasm to function as part of
the cell’s protein biosynthetic apparatus. Based on this scheme,
RPS14 mutations which preclude export of the encoded
ribosomal protein from the nucleolus to the cytoplasm are
961Human r-protein S14 mutationsinterpreted as abrogating S14’s incorporation into pre-
ribosomal subunit particles within the nucleolus. To be more
precise, RPS14 mutations which interfere with ribosomal
subunit assembly or maturation as well as mutations which
preclude export of mature 40 S ribosomal subunits to the
cytoplasm also might fall into this phenotypic class. Nonethe-
less, the assay described in this report permitted us to resolve
our collection of S14 null alleles into two phenotypic classes:
(i) alleles that encode ribosomal proteins which are incor-
porated into nonfunctional 40 S ribosomal subunits exported
to the cytoplasm; and (ii) alleles whose products accumulate
either as free ribosomal proteins or as structural components
of immature 40 S pre-ribosomal subunits within the nucleolus
and nucleoplasm. 
Detailed biochemical characterization is necessary to verify
the molecular status of S14 proteins encoded by the two classes
of null mutations described above. Unfortunately, the transient
expression assay employed in these studies is not suitable for
critical biochemical analysis because only small fractions of
cells within the CHO cell cultures (<10%) express the S14
transgenes. For this reason, detailed molecular analysis
requires homogenous, cloned populations of CHO cells which
continuously express the mutant transgenes. Toward this end,
we have attempted to isolate CHO cell lines stably transformed
with each of the S14 null alleles described in this report using
the polybrene-mediated protocol described in Materials and
Methods. Although this approach readily yielded cloned CHO
cell lines that constitutively express high levels of wild-type
(as illustrated by data in Fig. 2) and biologically functional
mutant S14 transgenes (Diaz and Roufa, 1992), repeatedTable 2. Evolutionary conservation of amino ac
GenBank
r-Protein S14 homologs* access. no. 31 43 45 49 50
Vertebrates:
Homo sapiens M13934 C H T G K
Cricetulus griseus M35008 d d d d d
Rattus norvegicus X15040 d d d d d
Arthropods:
Procambarus clarkii D14609 d d d d R
Drosophila melanogaster M21045 A d d d R
Nematode:
Caenorhabditis elegans U00033 A d d d R
Hydrozoan:
Podocoryne carnea X71384 A d d d d
Fungi:
Neurospora crassa X53734 A d d d R
Saccharomyces cerevisiae M16126 A d d d d
Kluveromyces lactis X59860 A d d d R
Protozoan:
Trypanosoma brucei M36124 V d d d R
Algae:
Chlamydomonas reinhardtii U06937 A d d d R
Plants:
Arabidopsis thaliana Z17690 ? ? ? ? ?
Zea mays P19950† A d d d R
*r-Protein S14 amino acid sequences deposited in the GenBank database. The a
Computer Group, Madison, WI). Each of the human S14 amino acid residues alter
as standard single-letter abbreviations. In subsequent rows, amino acids that occup
residue in human S14. ? indicates that the amino acid in this position is not known
†This is a Swiss-Prot database accession number. attempts to isolate cells which stably express S14 null alleles
all have failed. In every case, G418-resistant colonies were
obtained with lesser frequency (35-50%) than simultaneous
control transfections of the wild-type S14 transgene. More
importantly, none of the transformed cell lines isolated
expressed the transgenic T7.tagged S14 proteins or their
messenger RNAs (J. Martín-Nieto and D. J. Roufa, unpub-
lished). In light of these results, we concluded that continuous
expression of S14 null alleles under control of the human
RPS14 transcriptional promoter (Overman et al., 1993) is lethal
for CHO cells growing in tissue culture and that isolation of
viable cell lines which express the RPS14 null alleles must
await development of a transgene expression system driven by
a tightly regulated, conditional promoter.
Three features of our experimental protocol ensured that the
epitope label used in these studies did not adversely affect the
biological activities of S14 fusion proteins. First, the T7.Tag
epitope was chosen because it is small (19 amino acid residues)
and increases the size of S14 fusion polypeptides by only
~12%. Second, the T7.Tag epitope was inserted into S14
domain A, a functionally dispensable segment of the ribosomal
protein (Diaz and Roufa, 1992). And third, the biological
activity of epitopically labeled wild-type fusion protein was
demonstrated by the fact that it rescued the recessive, emetine
resistance phenotype encoded by the RPS14 allele carried by
CHO Emr-2-2 cells (Madjar et al., 1982, 1983; Nakamichi et
al., 1983; Rhoads and Roufa, 1985, 1987a). Data illustrated in
Fig. 2A indicate that transgenic wild-type S14 fusion protein
(Mr .18,000) was incorporated into functional Chinese
hamster 40 S ribosomes about as efficiently as the r-protein (Mrids involved in human RPS14 null mutations
r-Protein S14 amino acid residues 
70 74 98 111 114 117 123 124 126 127 131 133
S A R G S R G M I G D T
d d d d d d d d d d d d
d d d d d d d d d d d d
d d d d d d d d d d d d
d d d d d d d d d d d d
d d d d d d d d d d d d
d d d d d d d d d d d d
d d d d d d d d d d d d
d d d d A d d L d d d d
d d d d A d d L d d d d
d d d d A d d d d d d d
d d d d d d d d d d d d
d d d d d d d d d d d d
d d d d d d d d d d d d
mino acid sequences were aligned using the PileUp software tool (Genetics
ed by the null mutations analyzed in this report are listed at the top of the table
y the same positions in aligned sequences are listed. d denotes identity with the
. 
962 J. Martín-Nieto and D. J. Roufa.16,000) encoded by the cells’ endogenous emetine resistance
RPS14 allele.
Transitions among intracellular immunofluorescence
staining patterns displayed by CHO cells which expressed epi-
topically-labeled S14 minigenes (Fig. 4A) were surprisingly
slow. Others have used radioisotopic pulse labeling procedures
to demonstrate that nascent ribosomal proteins are transported
to the nucleolus and assembled into pre-ribosomal particles
within minutes of their synthesis in cultured mammalian cells
(Warner and Soeiro, 1967; Kumar and Warner, 1972).
Therefore, the kinetics we observed over a four-day period
probably reflected the times required for transiently expressing
cells to synthesize, process and accumulate sufficient amounts
of epitopically labeled ribosomal protein to permit its detection
by indirect immunofluorescence microscopy. 
All of the mutant RPS14 alleles described in this report
encode proteins that were efficiently transported to CHO cell
nucleoli, indicating that none of the point mutations examined
seriously compromised S14’s nucleolar localization. In
contrast, immunofluorescence analysis of the proteins
expressed from a series of epitopically-tagged RPS14 deletion,
insertion and substitution transgenes indicate that a basic ten
amino acid sequence near the protein’s carboxyl terminus,
RRKGGRRGRR, is essential for S14’s nuclear localization
(unpublished observations).
The final steps of eukaryotic ribosome biogenesis occur
within the cells’ nucleolus. Several nucleolar proteins have
been implicated in the assembly and maturation of ribosomal
subunit particles (Hugle et al., 1985; Steitz et al., 1988; Borer
et al., 1989; Meier and Blobel, 1992, 1994) as well as in the
export of mature ribosomal subunits to the cell’s cytoplasm
(Khanna-Gupta and Ware, 1989; Bataillé et al., 1990; Ware
and Khanna-Gupta, 1990). In addition, previous studies from
this laboratory indicate that r-protein S14 contributes signif-
icantly to the structural integrity of mammalian 40 S
ribosomal subunits. When 40 S ribosomes purified from an
emetine-resistant mutant CHO cell line were treated with 0.5
M KCl, a condition which is used routinely to purify wild-
type mammalian ribosomal subunits, they dissociated into a
pair of sub-ribosomal particles which lacked S14 as well as
several other structural r-proteins (Madjar et al., 1983). In
light of these observations, the null mutations which appear
to preclude S14’s incorporation into pre-ribosomal subunit
particles (listed under Group C in Table 1) are likely to affect
amino acid residues that mediate the associations between
S14 and other 40 S ribosomal structural proteins or partici-
pate in interactions between S14 and nucleolar proteins
involved in ribosomal subunit assembly, maturation and
transport.
It is interesting that sixteen of the seventeen amino acid
residues altered by randomly-induced null mutations in the
human RPS14 locus (all but Cys-31) are stringently conserved
among the RPS14 loci carried by diverse eukaryotic species
(Table 2). These include amino acids located within RPS14
domains B, C and D (Fig. 5). This striking pattern of evolu-
tionary conservation is consistent with our conclusion that
amino acid residues affected by null mutations in the human
RPS14 locus are essential for intracellular transport and
nucleolar processing of r-protein S14 as well as for the
protein’s biological activity in mature cytoplasmic 40 S
ribosomal subunits.The authors thank Dr Richard A. Consigli for his help with indirect
immunofluorescence microscopy and Dr David A. Rintoul for his
suggestions concerning this manuscript. They also acknowledge the
expert technical assistance provided by Mrs Andrea Fernandez, Mr
Ralph S. Najarian and Mrs Marla M. Pyle. This research was
supported by grants GM23013 and GM38932 from the National
Institute of General Medical Sciences and a postdoctoral research fel-
lowship to J.M.N. from the Kansas Health Foundation (Wichita, KS).
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Experiment Station.
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